Molecular Interactions between Transfected Human TCR, Immunodominant Myelin Basic Protein Peptide 152-165, and HLA-DR13

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3460-3471

  Hastings, Alice E ^a   Hurley, Carolyn Katovich ^a   Robinson, Eve D ^a   Salerno, Kilian ^a   Hernandez, Eric ^a   Richert, John R ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COMPLEMENTARY DNA; EPITOPE; HLA DR ANTIGEN; HLA DR13; HLA-DR13; HYBRID PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; PEPTIDE FRAGMENT; PRIMER DNA;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL LINE; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIGENS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DNA, COMPLEMENTARY; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0030587790     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. McFarland, H. F., and D. E. McFarlin. 1994. Immunologically mediated demyelinating diseases of the central and peripheral nervous system. In Samter's Immunological Diseases. M. Frank, ed. Little, Brown and Co., Boston, pp. 1081-1101.
2. Valli, A., A. Sette, L. Kappos, C. Oseroff, J. Sidney, G. Miescher, M. Hochberger, E. D. Albert, and L. Adorini. 1993. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91:616.
3. Vogt, A. B., H. Kropshofer, H. Kalbacher, M. Kalbus, H.-G. Rammensee, J. E. Coligan, and R. Martin. 1994. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J. Immunol. 153:1665.
4. Wucherpfennig, K. W., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. L. Strominger, and D. A. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:279.
5. Acha-Orbea, H., D. J. Mitchell, L. Timmermann, D. C. Wraith, G. S. Tausch, M. K. Waldor, S. S. Zamvil, H. O. McDevitt, and L. Steinman. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.
6. Bourdette, D. N., R. H. Whitham, Y. K. Chou, W. J. Morrison, J. Atherton, C. Kenny, D. Liefeid, G. A. Hashim, H. Offner, and A. A. Vandenbark. 1994. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J. Immunol. 152:2510.
7. Kumar, V., R. Tabibiazar, H. M. Geysen, and E. Sercarz. 1995. Immunodominant framework region 3 peptide from TCR Vβ8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 154:1941.
8. Brostoff, S. W., and D. W. Mason. 1984. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J. Immunol. 133:1938.
9. Martin, R., D. Jaraquemada, M. Flerlage, J. Richert, J. Whitaker, E. O. Long, D. E. McFarlin, and H. F. McFarland. 1990. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J. Immunol. 145:540.
10. Pette, M., K. Fujita, D. Wilkinson, D. M. Altmann, J. Trowsdale, G. Giegerich, A. Hinkkanen, J. T. Epplen, L. Kappos, and H. Wekerle. 1990. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA 87:7968.
11. Richert, J. R., E. D. Robinson, G. E. Deibler, R. E. Martenson, L. J. Dragovic, and M. W. Kies. 1989. Human cytotoxic T-cell recognition of a synthetic peptide of myelin basic protein. Ann. Neurol. 26:342.
12. Ota, K., M. Matsui, E. L. Milford, G. A. Mackin, H. L. Weiner, and D. A. Hafler. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183.
13. Zhang, J. W., R. Medaer, Y. Chin, E. van den Berg-Loonen, and J. C. M. Raus. 1992. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 32:330.
14. Martin, R., M. D. Howell, D. Jaraquemada, M. Flerlage, J. Richert, S. Brostoff, E. O. Long, D. E. McFarlin, and H. F. McFarland. 1991. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173:19.
15. Hauser, S. L., E. Fleischnick, H. L. Weiner, D. Marcus, Z. Awdeh, E. J. Yunis, and C. A. Alper. 1989. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology 39:275.
16. Gorodezky, C., R. Najera, B. E. Rangel, L. E. Castro, J. Flores, G. Velazquez, J. Granados, and J. Sotelo. 1986. Immunogenetics profile of multiple sclerosis in Mexicans. Hum. Immunol. 16:364.
17. Naito, S., Y. Kuroiwa, T. Itoyama, T. Tsubaki, A. Horikawa, T. Sasazuki, S. Noguchi, S. Ohtsuki, H. Tokumi, T. Miyatake, N. Takahata, S. Kawanami, and A, J. McMichael. 1995. HLA and Japanese multiple sclerosis. Tissue Antigens 12:19.
18. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DRI complexed with an influenza virus peptide. Nature 368:215.
19. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
20. Wucherpfennig, K. M., D. A. Hafler, and J. L. Strominger. 1995. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes. Proc. Natl. Acad. Sci. USA 92:8896.
21. Nepom, G. T., and H. Erlich. 1991. MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9:493.
22. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695.
23. Richert, J. R., E. D. Robinson, A. H. Johnson, M. L. Cohn, H. F. McFarland, and C. K. Hurley. 1995. Myelin basic protein-reactive human T-cell clones: stimulation by diverse microbial antigens. Ann. NY Acad. Sci. 756:319.
24. Utz, U., W. E. Biddison, H. F. McFarland, D. E. McFarlin, M. Flerlage, and R. Martin. 1993. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 364:243.
25. β usage to immunodominant regions of myelin basic protein. Science 248:1016.
26. Kotzin, B. L., S. Karuturi, Y. K. Chou, J. Lafferty, J. M. Forrester, M. Better, G. E. Nedwin, H. Offner, and A. A. Vandenbark. 1991. Preferential T-cell receptor β-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 88:9161.
27. Hawes, G. E., L. Struyk, B. C. Godthelp, and P. J. Van den Elsen. 1995. Limited restriction in the TCR-αβ V region usage of antigen-specific clones: recognition of myelin basic protein (amino acids 84-102) and Mycobacterium bovis 65-kDa heat shock protein (amino acids 3-13) by T cell clones established from peripheral blood mononuclear cells of monozygotic twins and HLA-identical individuals. J. Immunol. 154:555.
28. β gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc. Natl. Acad. Sci. USA 88:2466.
29. Richert, J. R., E. D. Robinson, K. Camphausen, R. Martin, R. R. Voskuhl, M. A. Faerber, H. F. McFarland, and C. K. Hurley. 1995. Diversity of T-cell receptor Vα, Vβ, and CDR3 expression by myelin basic protein-specific human T-cell clones. Neurology 45:1919.
30. Oksenberg, J. R., S. Stuart, A. B. Begovich, R. B. Bell, H. A. Erlich, L. Steinman, and C. C. A. Bernard. 1990. Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients. Nature 345:344.
31. Oksenberg, J. R., M. A. Panzara, A. B. Begovich, D. Mitchell, H. A. Erlich, R. S. Murray, R. Shimonkevitz, M. Sherritt, J. Rothbard, C. C. A. Bernard, and L. Steinman. 1993. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68.
32. Meinl, E., F. Weber, K. Drexler, C. Morelle, M. Ott, G. Saruhan-Direskeneli, N. Goebels, B. Ertl, G. Jechart, G. Giegerich, S. Schonbeck, W. Bannwarth, H. Wekerle, and R. Hohlfeld. 1993. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis: complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J. Clin. Invest. 92:2633.
33. Bhardwaj, V., V. Kumar, H. M. Geysen, and E. E. Sercarz. 1993. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells: implications for thymic education and autoimmunity. J. Immunol. 151: 5000.
34. Utz, U., J. A. Brooks, H. F. McFarland, R. Martin, and W. E. Biddison. 1994. Heterogeneity of T-cell receptor α-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis. Proc. Natl. Acad Sci. USA 91:5567.
35. Wucherpfennig, K. W., J. Newcombe, H. Li, C. Keddy, M. L. Cuzner, and D. A. Hafler. 1992. T cell receptor Vα-Vβ repertoire and cytokine gene expression in active multiple sclerosis lesions. J. Exp. Med. 175:993.
36. Hurley, C. K., and N. Steiner. 1995. Differences in peptide binding of DR11 and DR13 microvariants demonstrate the power of minor variation on DR functional diversity. Hum. Immunol. 43:101.
37. Posch, P. E., H. A. Araujo, K. Cresswell, C. Praud, A. Johnson, and C. K. Hurley. 1995. Microvariation creates significant functional differences in the DR3 molecules. Hum. Immunol. 42:61.
38. Letourneur, F., and B. Malissen. 1989. Derivation of a T cell hybridoma variant deprived of functional T cell receptor α and β chain transcripts reveals a non-functional α-mRNA of BW5147 origin. Eur. J. Immunol. 19:2269.
39. Hong, S.-C., A. Chelouche, R. Lin, D. Shaywitz, N. S. Braunstein, L. Glimcher, and C. A. Janeway, Jr. 1992. An MHC interaction site maps to the amino-terminal half of the T cell receptor α chain variable domain. Cell 69:999.
40. Rosen-Bronson, S., and D. Jaraquemada. 1991. On the relative immunogenicity of DR alloantigens: T cell recognition of HLA-DR2a and HLA-DR2b. Hum. Immunol. 30:215.
41. Posch, P. E., C. K. Hurley, A. Geluk, and T. H. M. Ottenhoff. 1995. DRβ26, DRβ28, DRβ47 and DRβ86 contribute to the peptide binding differences of the DR3 microvariants DR(α,β1*0301) and DR(α,β1*0302): the combinations of specific DRβ residues critical to binding differ for different peptides. Hum. Immunol. In press.
42. Richert, J. R., E. D. Robinson, A. H. Johnson, C. A. Bergman, L. J. Dragovic, N. L. Reinsmoen, and C. K. Hurley. 1991. Heterogeneity of the T-cell receptor β gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis. Ann. Neurol. 29:299.
43. Hurley, C. K., N. Steiner, A. Wagner, M. J. Geiger, D. D. Eckels, and S. Rosen-Bronson. 1993. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation. J. Immunol. 150:1314.
44. Novak, T. J., F. K. Yoshimura, and E. V. Rothenberg. 1992. In vitro transfection of fresh thymocytes and T cells shows subset-specific expression of viral promoters. Mol. Cell. Biol. 12:1515.
45. Brodsky, M. H., M. Wharton, R. M. Myers, and D. R. Littman. 1990. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J. Immunol. 144:3878.
46. Wei, S., P. Charmley, M. A. Robinson, and P. Concannon. 1994. The extent of the human germline T-cell receptor V beta gene segment repertoire. Immunogenetics 40:27.
47. Chothia, C., D. R. Boswell, and A. M. Lesk. 1988. The outline structure of the T-cell alpha beta receptor. EMBO J. 7:3745.
48. Moss, P. A. H., W. M. C. Rosenberg, E. Zintzaras, and J. I. Bell. 1993. Characterization of the human T cell receptor α-chain repertoire and demonstration of a genetic influence on Vα usage. Eur. J. Immunol. 23:1153.
49. lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511.
50. Emmrich, R., L. Kanz, and K. Eichmann. 1987. Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cells. Eur. J. Immunol. 17:529.
51. Testi, R., J. H. Phillips, and L. L. Lanier. 1989. Leu23 induction as an early marker of functional CD3/T cell antigen receptor triggering. J. Immunol. 142: 1854.
52. Kotzin, B. L., D. Y. M. Leung, J. Kappler, and P. Marrack. 1993. Superantigens and their potential role in human disease. Adv. Immunol. 54:99.
53. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745.
54. Bowness, P., P. A. H. Moss, H. Tranter, J. I. Bell, and A. J. McMichael. 1992. Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors Vβ6.9 and Vβ22. J. Exp. Med. 176:893.
55. Blank, U., B. Boitel, D. Mège, M. Ermonval, and O. Acuto. 1993. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma. Eur. J. Immunol. 23:3057.
56. Matsui, K., J. J. Boniface, P. A. Reay, H. Schild, B. Fazekas de St. Groth, and M. M. Davis. 1991. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788.
57. Weber, S., A. Traunecker, F. Oliveri, W. Gerhard, and K. Karjalainen. 1992. Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature 356:793.
58. Davenport, M. P., C. L. Quinn, R. M. Chicz, B. N. Green, A. C. Willis, W. S. Lane, J. I. Bell, and A. V. S. Hill. 1995. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRβ chain. Proc. Natl. Acad Sci. USA 92:6567.
59. Ehrich, E. W., B. Devaux, E. P. Rock, J. L. Jorgensen, M. M. Davis, and Y. Chien. 1993. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J. Exp. Med. 178:713.
60. Wall, M., J. Southwood, J. Sidney, C. Oseroff, M. F. del Gurecio, A. Lamont, S. M. Colon, T. Arrhenius, F. C. A. Gaeta, and A. Sette. 1992. High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants. Int. Immunol. 4:773.
61. Abromson-Leeman, S., J. Alexander, R. Bronson, J. Carroll, S. Southwood, and M. Dorf. 1995. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II. J. Immunol. 154: 388.
62. Jorgensen, J. L., U. Esser, B. Fazekas de St. Groth, P. A. Reay, and M. M. Davis. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224.
63. Chien, Y., and M. M. Davis. 1993. How αβ T-cell receptors 'see' peptide/MHC complexes. Immunol. Today 14:597.
64. Reay, P. A., R. M. Kantor, and M. M. Davis. 1994. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:3946.
65. Jorgensen, J. L., P. A. Reay, E. W. Ehrich, and M. M. Davis. 1992. Molecular components of T-cell recognition. Annu. Rev. Immunol. 10:835.